Cambridge, MA, United States of America

Glympse Bio, Inc.


USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 5

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Sophie Cazanave (4 out of 6 patents)

silverMedal Sangeeta N Bhatia (2 out of 61 patents)

bronzeMedal Sirshendu Roopom Banerjee (2 out of 3 patents)

4.  Eric Huang (2 out of 2 patents)

5.  Andrew Warren (2 out of 8 patents)

6.  Gabriel A Kwong (2 out of 16 patents)

7.  Mehar Cheema (2 out of 4 patents)

8.  Wendy Winckler Adamovich (2 out of 5 patents)

9.  Faycal Touti (2 out of 4 patents)

10.  Robert Samuel Langer (2 out of 636 patents)


4 patents:

Glympse Bio, Inc. is a biotechnology company focused on developing non-invasive diagnostic technologies for various diseases. They specialize in utilizing proprietary nanoparticle technology to detect and monitor biomarkers in the body, enabling early disease detection and personalized treatment. The company's innovative approach has the potential to revolutionize healthcare by providing more accurate and timely diagnostic solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#408 in Cambridge, MA

#3,305 in Massachusetts

#60,525 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 5

10 inventors:

Please report any incorrect information to [email protected]
Loading…